Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06685783Completed

Vis-Rx Prime Micro-Imaging Catheter Study

Role: lead

NCT06078878Not ApplicableRecruiting

Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter

Role: lead

NCT05312164Recruiting

Physio-Anatomy Clinical Data Collection Study

Role: lead

NCT04533503Completed

Vis-Rx Post-Market Evaluation

Role: lead

All 4 trials loaded